FFR与造影引导PCI在TAVI患者中的随机对照试验:FAITAVI研究
FAITAVI是一项多中心、开放标签、随机优效性试验,纳入320例接受TAVI且伴中等程度冠状动脉病变的主动脉瓣狭窄患者,1:1随机至FFR引导或造影引导PCI。12个月随访显示,FFR引导组MACCE发生率显著低于造影引导组(8.5% vs 16.0%;
要点
- TAVI伴中等冠脉病变患者中,FFR引导PCI较造影引导显著降低12个月MACCE。
- 该策略适用于高龄、衰弱TAVI人群的冠脉血运重建决策。
核心结论
- 在接受TAVI的中等程度冠状动脉病变患者中,FFR引导PCI与12个月MACCE风险降低相关。
- 研究结果支持在此衰弱老年人群中采用基于生理学的血运重建策略。
研究设计与样本
- 多中心、开放标签、随机优效性试验,不良事件采用盲法裁定,共纳入15家意大利中心的320例患者。
- 患者为主动脉瓣狭窄并接受TAVI、伴中等程度冠状动脉病变者,按1:1随机至FFR引导或造影引导PCI。
- 主要分析采用意向性治疗原则,纳入所有随机患者;主要终点为12个月MACCE。
主要发现
- 患者中位年龄86岁(IQR 83-90),中位STS评分3%(IQR 2-5),中位SYNTAX评分7(IQR 5-11)。
- 复合终点其他组分在数值上较低但未达统计学显著性。
临床怎么用
- 对拟行TAVI且伴中等程度冠状动脉病变的患者,可考虑采用FFR引导的PCI策略以降低12个月MACCE风险。
- 该策略在高龄、衰弱TAVI人群中显示出获益,支持基于生理学评估而非单纯造影指导血运重建。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The optimal approach to coronary revascularization in patients undergoing transcatheter aortic valve implantation (TAVI) remains debated. Fractional flow reserve (FFR) may improve the identification of ischaemia-producing lesions compared to angiographic assessment alone, but data in the TAVI population are lacking. METHODS: In this multicentric, open-label, randomized, superiority trial with blind adjudication of adverse events, patients with aortic stenosis and intermediate coronary lesions undergoing TAVI were randomized 1:1 to FFR-guided or angiography-guided percutaneous coronary intervention (PCI). The trial was registered at ClinicalTrials.gov (NCT03360591). All randomized patients were included in the primary analysis according to the intention-to-treat principle. The primary endpoint was a major adverse cardiac and cerebrovascular event (MACCE) at 12 months of follow-up, defined as a composite of all-cause death, myocardial infarction, ischaemia-driven target vessel revascularization, disabling stroke, or major bleeding. RESULTS: A total of 320 patients were enrolled across 15 Italian centres. The median age of the patients was 86 years [interquartile range (IQR) 83-90], and the median STS score was 3% (IQR 2-5). The median SYNTAX score was 7 (IQR 5-11). FFR-guided PCI was associated with a significantly lower rate of MACCE at 12 months compared with angiography-guided PCI (8.5% vs 16.0%; hazard ratio .52; 95% confidence interval .27-.99; P = .047). The difference in the primary endpoint was primarily driven by a reduction in all-cause mortality (hazard ratio .31; 95% confidence interval .10-.96). Other components of the composite were numerically lower but not statistically significant. CONCLUSIONS: In patients undergoing TAVI with intermediate coronary lesions, FFR-guided PCI was associated with a reduced risk of MACCE at 12 months. These findings support a physiology-based revascularization strategy in this frail, elderly population.
引用
- Ribichini FL, Scarsini R, Pesarini G, et al. Physiology vs angiography-guided percutaneous coronary intervention in transcatheter aortic valve implantation: the FAITAVI trial. Eur Heart J. 2026. PMID: 41417623. doi:10.1093/eurheartj/ehaf974
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。